No Match, No Deal In FSS Buy
Client Alert | 1 min read | 01.05.05
Reiterating once again that the exemption from full and open competition for orders placed under GSA’s Federal Supply Schedule contracts applies only to items and services in fact listed and priced in the FSS contracts, in American Sys. Consulting, Inc. (Dec. 13, 2004), GAO sustained a protest because the awardee’s Schedule contract description of education/experience and functional requirements for a particular job title did not match those for the RFQ position proposed to be filled. Neither the fact that the background of the individual proposed met the RFQ requirements nor the fact that the RFQ called for quotations citing the FSS job title that “mostly nearly equated” to the RFQ position cured the legal flaw, because the exemption from the competition requirements applies only to the items/services offered by the explicit terms of the Schedule contract.
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
